RecruitingNCT04258787

OCT in Fuchs' Dystrophy

Evaluating Corneal Edema in Fuchs' Endothelial Dystrophy Using Optical Coherence Tomography

Sponsor

Oregon Health and Science University

Enrollment

60 participants

Start Date

Jun 26, 2020

Study Type

OBSERVATIONAL

Conditions

Pseudophakic Bullous Keratopathy Fuchs Dystrophy

Summary

This is an observational study using optical coherence tomography (OCT) technology to quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from resolving corneal edema after surgical treatments.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with fuchs dystrophy and pseudophakic bullous keratopathy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Oregon Health & Science University

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04258787

Related Trials

OCT in Fuchs' Dystrophy

Conditions

Summary

Eligibility

Plain Language Summary

Locations(1)

Related Trials

Prognosis of Posterior Lamellar Keratoplasty

Descemet Endothelial Thickness Comparison Trial II

The Belgian Endothelial Surgical Transplant of the Cornea

PVEK Corneal Implant For Treatment of Corneal Edema

Study to Assess Safety and Tolerability of Multiple Doses of EO2002